Medical Devices North America

North America Tuberculosis Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Tuberculosis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.23 Bn Placeholder estimate
Estimate 2025 $1.30 Bn 50.3% of the global market
Projected 2034 $2.09 Bn 60.5% Adds $787.4 Mn over 9 forecast years
CAGR 2025–2034 5.4% Faster than 20% of 173 Medical Devices markets here
Key players 5
  • North America is 50.33% of the global market.
  • Among regions, the largest is North America (this report) at $1.30 Bn.
  • Fastest growing: APAC at 7.3% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$787.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tuberculosis Diagnostics Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.23 Bn — —
2025 (base) $1.30 Bn +$66.6 Mn —
2026 (forecast) $1.37 Bn +$70.2 Mn +5.4%
2027 (forecast) $1.45 Bn +$74.0 Mn +11.1%
2028 (forecast) $1.52 Bn +$78.0 Mn +17.1%
2029 (forecast) $1.61 Bn +$82.2 Mn +23.4%
2030 (forecast) $1.69 Bn +$86.7 Mn +30.1%
2031 (forecast) $1.78 Bn +$91.4 Mn +37.1%
2032 (forecast) $1.88 Bn +$96.3 Mn +44.5%
2033 (forecast) $1.98 Bn +$101.5 Mn +52.3%
2034 (forecast) $2.09 Bn +$107.0 Mn +60.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Tuberculosis Diagnostics Market Analysis at a glance
Market size, 2025$1.30 Bn placeholder estimate
Forecast, 2034$2.09 Bn placeholder estimate
Growth (CAGR), 2025–20345.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, setting and end user (see all)
Key playersCepheid, Qiagen N.V., Molbio Diagnostics, Qure.ai, Revvity (see all)
Active clinical trials12 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Tuberculosis Diagnostics Market Analysis Executive Summary

Tuberculosis diagnostics find TB infection and disease using skin tests, blood tests, molecular tests and chest X-ray reading.

Key segments of the tuberculosis Diagnostics market include test (Molecular Tests, Interferon Gamma Release Assays and Skin Tests) and setting (Hospitals, TB Programs and Point of Care).

Bar chart: North America Tuberculosis Diagnostics market size, 2024–2034, placeholder estimates. $1.23 Bn in 2024, $1.30 Bn in 2025 and $2.09 Bn in 2034, 5.4% CAGR.
North America Tuberculosis Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Tuberculosis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the tuberculosis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the tuberculosis Diagnostics market.

Competitive Landscape for Tuberculosis Diagnostics Market in North America

The tuberculosis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tuberculosis Diagnostics Market in North America

Tuberculosis Diagnostics in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 12 studies on Tuberculosis Diagnostics that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tuberculosis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tuberculosis Diagnostics right now, from free public sources.

Clinical trials

12 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. PT Bio Farma 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Shanghai Jiatan Pharmatech Co., Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tuberculosis Diagnostics in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tuberculosis Diagnostics market in North America?
Placeholder estimate: about $1.30 Bn in 2025, rising to about $2.09 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tuberculosis Diagnostics market in North America growing?
Placeholder estimate: about 5.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tuberculosis Diagnostics market report cover?
The report splits the market by test (Molecular Tests, Interferon Gamma Release Assays, Skin Tests, Sputum Smear and more), setting (Hospitals, TB Programs, Point of Care) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tuberculosis Diagnostics market?
Key players include Cepheid, Qiagen N.V., Molbio Diagnostics, Qure.ai and Revvity.
What is driving the Tuberculosis Diagnostics market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.
How many clinical trials on Tuberculosis Diagnostics are running in North America?
12 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Tuberculosis Diagnostics?
PubMed lists 80 papers on Tuberculosis Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on diagnostics and lab testing and tuberculosis

See the topic